Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Japan Clinical Cancer Research Organization (JCCRO) is a non-profit organization based in Tokyo that functions as a specialized contract research organization (CRO) for the oncology sector. Established in 2005, the organization provides the necessary infrastructure and expertise to conduct high-quality investigator-initiated clinical trials across Japan. JCCRO offers a comprehensive range of services, including protocol development, data management, site monitoring, and statistical analysis. By collaborating with academic institutions and pharmaceutical companies, JCCRO facilitates the clinical evaluation of novel therapeutic agents and the optimization of existing treatment protocols. The organization is dedicated to improving cancer survival rates and patient quality of life by ensuring that clinical research adheres to international Good Clinical Practice (GCP) standards. JCCRO plays a vital role in the Japanese healthcare ecosystem by bridging the gap between laboratory research and clinical application.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Japan Clinical Cancer Research Organization.